Our products are built on the Click Neurobehavioral Intervention (CNI) platform and powered by Clickometrics®, our machine learning and data science engine.

Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.

FutureCure Health develops technologies to diagnose and treat chronic diseases like migraine, dizziness, etc. FutureCure plans to launch various technologies for migraine patients, including wearable Neuromodulation and Biofeedback device. In addition, the digital therapeutics app will help identify the triggers using AI and help manage lifestyle changes. The interactive app will also provide Cognitive Behavioral Therapy (CBT).

FutureCure Health develops technologies to diagnose and treat chronic diseases like migraine, dizziness, etc. FutureCure plans to launch various technologies for migraine patients, including wearable Neuromodulation and Biofeedback device. In addition, the digital therapeutics app will help identify the triggers using AI and help manage lifestyle changes. The interactive app will also provide Cognitive Behavioral Therapy (CBT).